Key terms

About INSP

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest INSP news

Today 7:50am ET Analysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB) Yesterday 9:00am ET Analysts Offer Insights on Healthcare Companies: Diamedica Therapeutics (DMAC), Inspire Medical Systems (INSP) and Maravai Lifesciences Holdings (MRVI) Yesterday 8:24am ET UBS remains bullish on Inspire Medical after Lilly’s OSA results Yesterday 7:30am ET Analysts’ Top Healthcare Picks: Inspire Medical Systems (INSP), Eli Lilly & Co (LLY) Yesterday 5:57am ET Inspire Medical Systems: Assessing the Impact of Tirzepatide on Implant Sales and Maintaining a Hold Rating Apr 17 12:00pm ET Inspire Medical rises 7.8% Apr 17 10:39am ET Inspire rises, ResMed slips as Street digests data from Lilly sleep apnea trials Apr 17 9:47am ET Inspire Medical rises 6.0% Apr 17 9:25am ET Positive SURMOUNT-OSA Trial Results Reinforce Buy Rating for Inspire Medical Systems Apr 17 9:15am ET KeyBanc views Lilly’s SURMOUNT-OSA results as ‘a bit of a relief’ for Inspire Apr 17 9:14am ET Lilly OSA results ‘small net-positive’ for Inspire Medical, says Morgan Stanley Apr 17 9:11am ET JPMorgan says Lilly data positive for Inspire Medical, buy shares Apr 17 8:55am ET ResMed, Inspire Medical slip after Lilly sleep apnea trials meet goal Apr 16 6:55am ET Inspire Medical Systems (INSP) was downgraded to a Hold Rating at Stifel Nicolaus Mar 22 7:40am ET Analysts Offer Insights on Healthcare Companies: Bruker (BRKR), Inspire Medical Systems (INSP) and Pfizer (PFE) Mar 22 5:18am ET Wells Fargo Releases a Hold Rating on Inspire Medical Systems (INSP) Mar 21 2:20am ET Leerink Partners Remains a Hold on Inspire Medical Systems (INSP) Mar 20 5:11pm ET Analysts Conflicted on These Healthcare Names: Inspire Medical Systems (INSP), ACELYRIN, INC. (SLRN) and Vera Therapeutics (VERA) Mar 20 2:38pm ET LivaNova jumps nearly 12% after saying trial likely to meet primary endpoint Mar 19 9:53am ET Snowflake, MongoDB downgraded to Sell: Wall Street’s top analyst calls Mar 19 8:05am ET Truist Financial Gives a Buy Rating to Inspire Medical Systems (INSP) Mar 19 5:54am ET Inspire Medical initiated with an Overweight at Morgan Stanley Mar 04 9:10am ET Inspire Medical growth intact despite GLP-1 fears, says UBS Feb 27 5:21pm ET Inspire Medical reports Q3 adjusted EPS 17c vs. 41c last year Feb 13 6:02am ET ‘Fundamentals Appear Positive’: KeyBanc Suggests 2 MedTech Stocks With up to ~40% Upside Feb 13 5:09am ET Inspire Medical Systems: Holding Position Amidst Regulatory Challenges and Market Shifts Feb 11 1:01am ET Inspire Medical’s New Regulation Risk – A Cause for Worry? Feb 07 9:06am ET Inspire Medical price target raised to $280 from $265 at Truist Feb 07 8:54am ET Inspire Medical price target raised to $270 from $240 at Lake Street Feb 07 8:41am ET Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Qiagen (QGEN) and Inspire Medical Systems (INSP) Feb 07 8:30am ET Inspire Medical price target raised to $265 from $230 at BofA

INSP Financials

1-year income & revenue

Key terms

INSP Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

INSP Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms